Disparities in care and outcomes are common, complex problems and are well illustrated by heart failure, from the initial diagnosis to the treatment of advanced disease. In the US, Black individuals develop heart failure at a much younger age than individuals of other races, and the incidence for Black individuals is 50% higher than that for White individuals. 1 Although the age-adjusted hospitalization rate for Black patients with heart failure in the US has decreased over the past 20 years, it was still approximately 2.2 times the rate for White patients in 2018. 2 There is also a concern for disparities in unrecognized heart failure among Black patients and among female patients, as they are more likely to be diagnosed in the acute care setting despite having symptoms for months before diagnosis. 3 The increased risk extends to those with end-stage heart failure, with Black patients accounting for 26.5% of hospitalizations coded as end-stage heart failure (2017-2020), 4 which is double their 12.1% share of the overall US population in the 2020 US census.The optimal treatment of end-stage heart failure is heart transplant, and the first step is to be placed on the transplant waiting list. In 1987, only 7% of those listed for transplant were self-identified as Black, but this number rose to 25% in 2019. 5 Once listed, priority status is assigned based on standard criteria, although listing priority can be changed if the transplant team requests and is granted an exception. 6 Despite the high cost and limited number of available donor organs, the total number of heart transplants has continued to improve for all groups, with 26% of heart transplants occurring in Black patients in 2019, up from 5% of all heart transplants in 1987. 5 However, worrisome racial and ethnic differences persist. Among those listed from 2011 to 2020, Asian patients had the greatest probability of receiving a transplant (adjusted hazard ratio [AHR], 1.38; 95% CI, 1.28-1.48) followed by Hispanic patients (AHR, 1.04; 95% CI, 0.99-1.09) and then Black patients (AHR, 0.87; 95% CI, 0.84-0.90), all compared with White patients. 7 The difference in transplant rate between Black and White patients appears to be decreasing over time. 5 Moreover, there is evidence of fewer heart transplant listings for female patients. From 2011 to 2021, the percentage of wait-listed female patients decreased from 26% to 24%, 8 while the percentage of hospitalizations coded for end-stage heart failure in women was 29% (2017-2020). 3 Concomitantly (2011-2021), the percentage of transplant recipients who were female decreased from 28% to 26%. 8 Overall, however, women have a higher rate of transplant, with 120 transplants per 100 patient-years on the waiting list compared with 100 transplants per 100 patient-years for men. 8